BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30523493)

  • 1. Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors.
    Łastowska M; Trubicka J; Karkucińska-Więckowska A; Kaleta M; Tarasińska M; Perek-Polnik M; Sobocińska AA; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Brain Tumor Pathol; 2019 Jan; 36(1):1-6. PubMed ID: 30523493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.
    Silva Rd; Marie SK; Uno M; Matushita H; Wakamatsu A; Rosemberg S; Oba-Shinjo SM
    Clinics (Sao Paulo); 2013; 68(2):167-72. PubMed ID: 23525311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.
    Goschzik T; Zur Mühlen A; Kristiansen G; Haberler C; Stefanits H; Friedrich C; von Hoff K; Rutkowski S; Pfister SM; Pietsch T
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):135-44. PubMed ID: 24894640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel inherited ALK variant M1199L in the WNT type of medulloblastoma.
    Trubicka J; Szperl M; Grajkowska W; Karkucińska-Więckowska A; Tarasińska M; Falana K; Dembowska-Bagińska B; Łastowska M
    Folia Neuropathol; 2016; 54(1):23-30. PubMed ID: 27179218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas.
    Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
    Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients.
    Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Tarasińska M; Perek-Polnik M; Krętowski A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Matyja E
    Am J Surg Pathol; 2017 Jun; 41(6):781-787. PubMed ID: 28338501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
    Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
    J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
    Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
    Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
    Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC and CTNNB1 mutations are rare in sporadic ependymomas.
    Onilude OE; Lusher ME; Lindsey JC; Pearson AD; Ellison DW; Clifford SC
    Cancer Genet Cytogenet; 2006 Jul; 168(2):158-61. PubMed ID: 16843107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
    Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
    Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
    J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular distribution of beta-catenin in human medulloblastoma cell lines with different degree of neuronal differentiation.
    Salaroli R; Russo A; Ceccarelli C; Mina GD; Arcella A; Martinelli GN; Giangaspero F; Capranico G; Cenacchi G
    Ultrastruct Pathol; 2007; 31(1):33-44. PubMed ID: 17455096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.
    Clifford SC; Lusher ME; Lindsey JC; Langdon JA; Gilbertson RJ; Straughton D; Ellison DW
    Cell Cycle; 2006 Nov; 5(22):2666-70. PubMed ID: 17172831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
    Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
    Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
    Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
    Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
    Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
    Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
    Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
    Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.